Debio-0617B

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDebio-0617B
Drug Alias NameDebio-0617
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitorsTyrosine-protein kinase SRC inhibitors
TargetsJanus kinaseTyrosine-protein kinase SRC
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDebiopharm GroupAurigene
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDebiopharm GroupAurigene
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A